A Phase I Dose Escalation Study of Darinaparsin in Combination With CHOP in Previously Untreated Patients With Lymphomas Who Are Scheduled to Receive CHOP Alone.

Trial Profile

A Phase I Dose Escalation Study of Darinaparsin in Combination With CHOP in Previously Untreated Patients With Lymphomas Who Are Scheduled to Receive CHOP Alone.

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 10 Oct 2013

At a glance

  • Drugs Darinaparsin (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
  • Indications B cell lymphoma; Hodgkin's disease; Non-Hodgkin's lymphoma; T cell lymphoma
  • Focus Adverse reactions
  • Most Recent Events

    • 26 May 2011 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 13 Oct 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 09 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top